Odonate Therapeutics, Inc. Financing Cash Flow
Odonate Therapeutics, Inc. reported Financing Cash Flow of $825.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-11-10
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $825.00K, a 58.35% increase year-over-year.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $524.00K, a 56.37% decline year-over-year.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $90.37M, a 34.84% decline from fiscal 2019.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $138.68M, a 1259.98% increase from fiscal 2018.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $10.20M, a 95.40% decline from fiscal 2017.
- Odonate Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2017 was $221.45M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $825.00K 10-Q · filed 2021-11-10 | $1.35M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $825.00K 10-Q · filed 2021-07-27 | $1.35M derived: sum of 3 quarters · filed 2021-07-27 | $89.54M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $825.00K 10-Q · filed 2021-05-14 | $1.35M derived: sum of 2 quarters · filed 2021-05-14 | $89.54M derived: sum of 3 quarters · filed 2021-11-10 | $90.67M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $88.71M derived: sum of 2 quarters · filed 2021-11-10 | $89.85M derived: sum of 3 quarters · filed 2021-11-10 | $90.37M 10-K · filed 2021-02-23 |
| 2020-09-30 | $88.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $89.32M derived: sum of 2 quarters · filed 2021-11-10 | $89.84M 10-Q · filed 2021-11-10 | $91.04M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $1.65M 10-Q · filed 2021-07-27 | $2.85M derived: sum of 3 quarters · filed 2021-07-27 | $22.04M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $521.00K 10-Q · filed 2021-05-14 | $1.72M derived: sum of 2 quarters · filed 2021-05-14 | $20.91M derived: sum of 3 quarters · filed 2021-05-14 | $139.04M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $20.39M derived: sum of 2 quarters · filed 2021-02-23 | $138.52M derived: sum of 3 quarters · filed 2021-02-23 | $138.68M 10-K · filed 2021-02-23 |
| 2019-09-30 | $19.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $137.32M derived: sum of 2 quarters · filed 2020-10-28 | $137.48M 10-Q · filed 2020-10-28 | $137.62M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | $118.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $118.29M 10-Q · filed 2020-07-30 | $118.43M derived: sum of 3 quarters · filed 2020-07-30 | $118.54M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $159.00K 10-Q · filed 2020-04-28 | $303.00K derived: sum of 2 quarters · filed 2020-04-28 | $410.00K derived: sum of 3 quarters · filed 2020-04-28 | $508.00K derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $251.00K derived: sum of 2 quarters · filed 2020-02-20 | $349.00K derived: sum of 3 quarters · filed 2020-02-20 | $10.20M 10-K · filed 2020-02-20 |
| 2018-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $205.00K derived: sum of 2 quarters · filed 2019-11-06 | $10.05M 10-Q · filed 2019-11-06 | $147.74M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $9.95M 10-Q · filed 2019-07-24 | $147.64M derived: sum of 3 quarters · filed 2019-07-24 | $221.41M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | $9.85M 10-Q · filed 2019-04-25 | $147.54M derived: sum of 2 quarters · filed 2019-04-25 | $221.31M derived: sum of 3 quarters · filed 2019-04-25 | |
| 2017-12-31 | $137.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $211.46M derived: sum of 2 quarters · filed 2019-02-22 | $221.45M 10-K · filed 2019-02-22 | |
| 2017-09-30 | $73.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $83.76M 10-Q · filed 2018-10-23 | ||
| 2017-06-30 | $9.98M 10-Q · filed 2018-07-30 |